Palopegteriparatide
Protein
Overview
Palopegteriparatide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL5095475).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Palopegteriparatide expires 12 Nov 2042 and exclusivity 9 Aug 2031. Generic API sourcing typically opens up once these lapse.
Verified Supplier Partner
Do you supply Palopegteriparatide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.